Covenant Cancer Treatment Center
Waterloo, Iowa, United States
Medical clinic in Waterloo, Iowa
200 E Ridgeway Ave, Waterloo, IA 50702
About Covenant Cancer Treatment Center
"We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
16
Alliance for Clinical Trials in Oncology
7
NSABP Foundation Inc
6
SWOG Cancer Research Network
6
ECOG-ACRIN Cancer Research Group
2
Eastern Cooperative Oncology Group
1
Helsinn Healthcare SA
1
University of South Florida
1
Clinical Trials at Covenant Cancer Treatment Center
During the past decade, Covenant Cancer Treatment Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 24 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
2004-01-01
2009-04-01
Completed
766
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
2003-11-01
2023-09-01
Active, not recruiting
545
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
2004-01-01
2014-10-01
Completed
645
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Covenant Cancer Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials
sponsored, "NSABP Foundation Inc" with 6 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 6 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Covenant Cancer Treatment Center"
#1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Covenant Cancer Treatment Center
According to Clinical.Site data, the most researched conditions in "Covenant Cancer Treatment Center" are
"Breast Cancer" (7 trials), "Breast Adenocarcinoma" (3 trials), "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Covenant Cancer Treatment Center" in a lesser frequency.
Clinical Trials Intervention Types at Covenant Cancer Treatment Center
Most popular intervention types in "Covenant Cancer Treatment Center" are "Drug" (35 trials), "Other" (22 trials), "Biological" (16 trials), "Radiation" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "Quality-of-Life Assessment" (8 trials), "Cyclophosphamide" (5 trials), "placebo" (5 trials) and "Doxorubicin Hydrochloride" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Covenant Cancer Treatment Center
The vast majority of trials in "Covenant Cancer Treatment Center" are
27 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Covenant Cancer Treatment Center
Currently, there are NaN active trials in "Covenant Cancer Treatment Center".
undefined are not yet recruiting,
1 are recruiting,
17 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Covenant Cancer Treatment Center,
1 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Covenant Cancer Treatment Center, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 34 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".